Skip to content

Comparing the effectiveness of Nirgundi taila Vranabasti and Jatyaditaila Vranabasti in treating Chronic non healing ulcer

A comparative clinical study to evaluate the efficacy of Vranabasti with Nirgundi Taila and Jatyadi Taila in the management of Dustavrana (Non-Healing Ulcer) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/069897
Enrollment
60
Registered
2024-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Veena Kangalavar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patient with irrespective of sex and occupation will be consider for the study patient with age 17 to 70 years, clinically diagnosed with dushta vrana with size of 3 to 10cm all types of non-specific ulcer will be included

Exclusion criteria

Exclusion criteria: patient having complications like Malignancy,Gangrene,Leprosy,Tuberclosis wound. patient with age less than 17 years and more 70 years. Pregnant and lactating wound will be excluded wound with excessive loss of tissue patient with HIV, HbSAg, HCV

Design outcomes

Primary

MeasureTime frame
To reduce prolonged wound healing duration To remove dead tissue and to promote healthy granulation tissueTimepoint: Main procedure for 14 days and follow up once in a week up to six weeks

Secondary

MeasureTime frame
wound discharge Foul smell & size of the ulcer measured by wound tracing method or clock methodTimepoint: 56days

Countries

India

Contacts

Public ContactDr Duradundi Gudasi

Dr.N.A.MAGADUM AYURVEDIC MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTER, ANKALI-591213

duradundi85@gmail.com9743192805

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026